Search

everythinglearnresearchcommunity

for

Search:↓

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

5α-Reductase inhibitors can negatively impact sexual function.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Finasteride 1 mg/day reduces semen quality without affecting hormones or sexual function.

Finasteride may help treat BPH by affecting certain biological markers.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Low doses of Coffea arabica seed extract prevent prostate growth and lower uric acid and PSA levels.

Finasteride can still be used for hair loss with careful consideration of side effects and patient information.

Early detection and treatment of urinary symptoms can help maintain functional ability in older adults.

Dutasteride does not seem to change rat spermatogenesis or oxidative stress.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

In 2005, men used finasteride mainly to treat an enlarged prostate.

Finasteride can cause sexual side effects like decreased libido and erectile dysfunction.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The document's conclusion cannot be determined without content.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.